Utility of Aminotransferase/Platelet Ratio Index to Predict Liver Fibrosis in Intestinal Failure–Associated Liver Disease in Pediatric Patients
- Autores
- Rumbo, Carolina; Martínez, María Inés; Cabanne, Ana; Trentadue, Julio; Fernández, Adriana; Gondolesi, Gabriel Eduardo
- Año de publicación
- 2016
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- BACKGROUND: Intestinal failure-associated liver disease (IFALD) is a frequent indication for intestinal transplantation. Liver biopsy (LBX) is the gold standard test for its diagnosis. Identifying noninvasive markers of fibrosis progression would be of considerable clinical use. Aspartate aminotransferase/platelet ratio index (APRI) has a good correlation in adult patients with chronic liver disease; few studies have been performed in children with IFALD.AIM:To evaluate APRI in a cohort of children with IFALD. MATERIALS AND METHODS: Retrospective analysis of a prospective database of patients <18 years with severe intestinal failure and at least 1 LBX, registered in our unit from March 2006 to December 2014. RESULTS: Forty-nine LBX were done on 36 patients: 20 were male, and 31 had short gut. Fibrosis was found in 71% of LBX. Biopsies were grouped according to the fibrosis stage (METAVIR [M]): (1) group 1 (G1) LBX with M 0, 1, 2 (n = 33) and (2) group 2 (G2) LBX with M 3, 4 (n = 16). The median APRI score was 0.92 (interquartile range [IQR] 0.63-1.50) for G1 and 2.50 (IQR 1.81-5.82) for G2 (P = .001) The c statistic of the receiving operating characteristic curve was 0.79 (95% CI 0.64-0.94; P < .001). The analyses allowed identifying a cutoff value for APRI of 1.6 as the point with the best sensitivity (81%) and specificity (76%) to predict advanced fibrosis. CONCLUSIONS: APRI in this cohort of patients shows that a score >1.6 correlates with advanced fibrosis.
Fil: Rumbo, Carolina. Universidad Favaloro; Argentina. Fundación Favaloro; Argentina
Fil: Martínez, María Inés. Universidad Favaloro; Argentina. Fundación Favaloro; Argentina
Fil: Cabanne, Ana. Universidad Favaloro; Argentina. Fundación Favaloro; Argentina
Fil: Trentadue, Julio. Universidad Favaloro; Argentina. Fundación Favaloro; Argentina
Fil: Fernández, Adriana. Universidad Favaloro; Argentina. Fundación Favaloro; Argentina
Fil: Gondolesi, Gabriel Eduardo. Universidad Favaloro; Argentina. Fundación Favaloro; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina - Materia
-
Apri
Intestinal Failure
Parenteral Nutrition
Liver Fibrosis - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/42392
Ver los metadatos del registro completo
id |
CONICETDig_9151c1a4ef56ca5c1d9cfeb7c12224d7 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/42392 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Utility of Aminotransferase/Platelet Ratio Index to Predict Liver Fibrosis in Intestinal Failure–Associated Liver Disease in Pediatric PatientsRumbo, CarolinaMartínez, María InésCabanne, AnaTrentadue, JulioFernández, AdrianaGondolesi, Gabriel EduardoApriIntestinal FailureParenteral NutritionLiver Fibrosishttps://purl.org/becyt/ford/3.2https://purl.org/becyt/ford/3BACKGROUND: Intestinal failure-associated liver disease (IFALD) is a frequent indication for intestinal transplantation. Liver biopsy (LBX) is the gold standard test for its diagnosis. Identifying noninvasive markers of fibrosis progression would be of considerable clinical use. Aspartate aminotransferase/platelet ratio index (APRI) has a good correlation in adult patients with chronic liver disease; few studies have been performed in children with IFALD.AIM:To evaluate APRI in a cohort of children with IFALD. MATERIALS AND METHODS: Retrospective analysis of a prospective database of patients <18 years with severe intestinal failure and at least 1 LBX, registered in our unit from March 2006 to December 2014. RESULTS: Forty-nine LBX were done on 36 patients: 20 were male, and 31 had short gut. Fibrosis was found in 71% of LBX. Biopsies were grouped according to the fibrosis stage (METAVIR [M]): (1) group 1 (G1) LBX with M 0, 1, 2 (n = 33) and (2) group 2 (G2) LBX with M 3, 4 (n = 16). The median APRI score was 0.92 (interquartile range [IQR] 0.63-1.50) for G1 and 2.50 (IQR 1.81-5.82) for G2 (P = .001) The c statistic of the receiving operating characteristic curve was 0.79 (95% CI 0.64-0.94; P < .001). The analyses allowed identifying a cutoff value for APRI of 1.6 as the point with the best sensitivity (81%) and specificity (76%) to predict advanced fibrosis. CONCLUSIONS: APRI in this cohort of patients shows that a score >1.6 correlates with advanced fibrosis.Fil: Rumbo, Carolina. Universidad Favaloro; Argentina. Fundación Favaloro; ArgentinaFil: Martínez, María Inés. Universidad Favaloro; Argentina. Fundación Favaloro; ArgentinaFil: Cabanne, Ana. Universidad Favaloro; Argentina. Fundación Favaloro; ArgentinaFil: Trentadue, Julio. Universidad Favaloro; Argentina. Fundación Favaloro; ArgentinaFil: Fernández, Adriana. Universidad Favaloro; Argentina. Fundación Favaloro; ArgentinaFil: Gondolesi, Gabriel Eduardo. Universidad Favaloro; Argentina. Fundación Favaloro; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaSAGE Publications2016-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/42392Rumbo, Carolina; Martínez, María Inés; Cabanne, Ana; Trentadue, Julio; Fernández, Adriana; et al.; Utility of Aminotransferase/Platelet Ratio Index to Predict Liver Fibrosis in Intestinal Failure–Associated Liver Disease in Pediatric Patients; SAGE Publications; Journal of Parenteral and Enteral Nutrition; 41; 5; 1-2016; 884-8890148-6071CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://onlinelibrary.wiley.com/doi/abs/10.1177/0148607115625779info:eu-repo/semantics/altIdentifier/doi/10.1177/0148607115625779info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-10T13:05:02Zoai:ri.conicet.gov.ar:11336/42392instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-10 13:05:03.024CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Utility of Aminotransferase/Platelet Ratio Index to Predict Liver Fibrosis in Intestinal Failure–Associated Liver Disease in Pediatric Patients |
title |
Utility of Aminotransferase/Platelet Ratio Index to Predict Liver Fibrosis in Intestinal Failure–Associated Liver Disease in Pediatric Patients |
spellingShingle |
Utility of Aminotransferase/Platelet Ratio Index to Predict Liver Fibrosis in Intestinal Failure–Associated Liver Disease in Pediatric Patients Rumbo, Carolina Apri Intestinal Failure Parenteral Nutrition Liver Fibrosis |
title_short |
Utility of Aminotransferase/Platelet Ratio Index to Predict Liver Fibrosis in Intestinal Failure–Associated Liver Disease in Pediatric Patients |
title_full |
Utility of Aminotransferase/Platelet Ratio Index to Predict Liver Fibrosis in Intestinal Failure–Associated Liver Disease in Pediatric Patients |
title_fullStr |
Utility of Aminotransferase/Platelet Ratio Index to Predict Liver Fibrosis in Intestinal Failure–Associated Liver Disease in Pediatric Patients |
title_full_unstemmed |
Utility of Aminotransferase/Platelet Ratio Index to Predict Liver Fibrosis in Intestinal Failure–Associated Liver Disease in Pediatric Patients |
title_sort |
Utility of Aminotransferase/Platelet Ratio Index to Predict Liver Fibrosis in Intestinal Failure–Associated Liver Disease in Pediatric Patients |
dc.creator.none.fl_str_mv |
Rumbo, Carolina Martínez, María Inés Cabanne, Ana Trentadue, Julio Fernández, Adriana Gondolesi, Gabriel Eduardo |
author |
Rumbo, Carolina |
author_facet |
Rumbo, Carolina Martínez, María Inés Cabanne, Ana Trentadue, Julio Fernández, Adriana Gondolesi, Gabriel Eduardo |
author_role |
author |
author2 |
Martínez, María Inés Cabanne, Ana Trentadue, Julio Fernández, Adriana Gondolesi, Gabriel Eduardo |
author2_role |
author author author author author |
dc.subject.none.fl_str_mv |
Apri Intestinal Failure Parenteral Nutrition Liver Fibrosis |
topic |
Apri Intestinal Failure Parenteral Nutrition Liver Fibrosis |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.2 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
BACKGROUND: Intestinal failure-associated liver disease (IFALD) is a frequent indication for intestinal transplantation. Liver biopsy (LBX) is the gold standard test for its diagnosis. Identifying noninvasive markers of fibrosis progression would be of considerable clinical use. Aspartate aminotransferase/platelet ratio index (APRI) has a good correlation in adult patients with chronic liver disease; few studies have been performed in children with IFALD.AIM:To evaluate APRI in a cohort of children with IFALD. MATERIALS AND METHODS: Retrospective analysis of a prospective database of patients <18 years with severe intestinal failure and at least 1 LBX, registered in our unit from March 2006 to December 2014. RESULTS: Forty-nine LBX were done on 36 patients: 20 were male, and 31 had short gut. Fibrosis was found in 71% of LBX. Biopsies were grouped according to the fibrosis stage (METAVIR [M]): (1) group 1 (G1) LBX with M 0, 1, 2 (n = 33) and (2) group 2 (G2) LBX with M 3, 4 (n = 16). The median APRI score was 0.92 (interquartile range [IQR] 0.63-1.50) for G1 and 2.50 (IQR 1.81-5.82) for G2 (P = .001) The c statistic of the receiving operating characteristic curve was 0.79 (95% CI 0.64-0.94; P < .001). The analyses allowed identifying a cutoff value for APRI of 1.6 as the point with the best sensitivity (81%) and specificity (76%) to predict advanced fibrosis. CONCLUSIONS: APRI in this cohort of patients shows that a score >1.6 correlates with advanced fibrosis. Fil: Rumbo, Carolina. Universidad Favaloro; Argentina. Fundación Favaloro; Argentina Fil: Martínez, María Inés. Universidad Favaloro; Argentina. Fundación Favaloro; Argentina Fil: Cabanne, Ana. Universidad Favaloro; Argentina. Fundación Favaloro; Argentina Fil: Trentadue, Julio. Universidad Favaloro; Argentina. Fundación Favaloro; Argentina Fil: Fernández, Adriana. Universidad Favaloro; Argentina. Fundación Favaloro; Argentina Fil: Gondolesi, Gabriel Eduardo. Universidad Favaloro; Argentina. Fundación Favaloro; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina |
description |
BACKGROUND: Intestinal failure-associated liver disease (IFALD) is a frequent indication for intestinal transplantation. Liver biopsy (LBX) is the gold standard test for its diagnosis. Identifying noninvasive markers of fibrosis progression would be of considerable clinical use. Aspartate aminotransferase/platelet ratio index (APRI) has a good correlation in adult patients with chronic liver disease; few studies have been performed in children with IFALD.AIM:To evaluate APRI in a cohort of children with IFALD. MATERIALS AND METHODS: Retrospective analysis of a prospective database of patients <18 years with severe intestinal failure and at least 1 LBX, registered in our unit from March 2006 to December 2014. RESULTS: Forty-nine LBX were done on 36 patients: 20 were male, and 31 had short gut. Fibrosis was found in 71% of LBX. Biopsies were grouped according to the fibrosis stage (METAVIR [M]): (1) group 1 (G1) LBX with M 0, 1, 2 (n = 33) and (2) group 2 (G2) LBX with M 3, 4 (n = 16). The median APRI score was 0.92 (interquartile range [IQR] 0.63-1.50) for G1 and 2.50 (IQR 1.81-5.82) for G2 (P = .001) The c statistic of the receiving operating characteristic curve was 0.79 (95% CI 0.64-0.94; P < .001). The analyses allowed identifying a cutoff value for APRI of 1.6 as the point with the best sensitivity (81%) and specificity (76%) to predict advanced fibrosis. CONCLUSIONS: APRI in this cohort of patients shows that a score >1.6 correlates with advanced fibrosis. |
publishDate |
2016 |
dc.date.none.fl_str_mv |
2016-01 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/42392 Rumbo, Carolina; Martínez, María Inés; Cabanne, Ana; Trentadue, Julio; Fernández, Adriana; et al.; Utility of Aminotransferase/Platelet Ratio Index to Predict Liver Fibrosis in Intestinal Failure–Associated Liver Disease in Pediatric Patients; SAGE Publications; Journal of Parenteral and Enteral Nutrition; 41; 5; 1-2016; 884-889 0148-6071 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/42392 |
identifier_str_mv |
Rumbo, Carolina; Martínez, María Inés; Cabanne, Ana; Trentadue, Julio; Fernández, Adriana; et al.; Utility of Aminotransferase/Platelet Ratio Index to Predict Liver Fibrosis in Intestinal Failure–Associated Liver Disease in Pediatric Patients; SAGE Publications; Journal of Parenteral and Enteral Nutrition; 41; 5; 1-2016; 884-889 0148-6071 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://onlinelibrary.wiley.com/doi/abs/10.1177/0148607115625779 info:eu-repo/semantics/altIdentifier/doi/10.1177/0148607115625779 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
SAGE Publications |
publisher.none.fl_str_mv |
SAGE Publications |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1842980174623145984 |
score |
12.993085 |